📰 Full Data Readout Expected News
Full Data Readout Expected News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Full Data Readout Expected. Real-time updates on events, politics, business and more.
August 17, 2023
/PRNewswire/ -- Immunic, Inc. (Nasdaq: IMUX), a biotechnology company developing a clinical pipeline of orally administered, small molecule therapies for...
August 17, 2023
Issuer: Immunic, Inc. / Key word(s): Study Immunic Completes Enrollment of Its Phase 2 CALLIPER Trial of Vidofludimus Calcium in Progressive Multiple Sclerosis 17.08.2023 / 12:30 CET/CEST The issuer is solely responsible for the content of this announcement. Immunic Completes Enrollment of Its P...